CERTARA
Certara provides biosimulation software and technology-enabled services that model drug behavior to support pharmaceutical research, development, and regulatory submissions.
2 tracked filer(s) hold this · 1 opened, 0 added, 1 trimmed in 30-SEP-2025
Aggregate 13FScore 44 — mean of 2 scored holder(s) · buyers (new/add) avg 49. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Bridgewater | 49 | New buy | 19,122 | $233,671 | 0.0% |
| Ancora | 38 | Trimmed -48% | 21 | $257 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
5 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-07-01 | Trump, Donald J President | SELL | $15,001 - $50,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | SELL | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| Report | Date | Stance |
|---|
| #92 — Market Memo: Talk to Me, Goose | 2025-04-13 | LONG |
| #84 — Market Memo: Healthcare's AI-Powered Trump Card | 2025-02-09 | LONG |